Home › Uveal Melanoma › Tennessee › Nashville
Uveal Melanoma clinical trials in Nashville, TN
6 studies for Uveal Melanoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
RecruitingPhase 3
- Sarah Cannon Research Institute (SCRI), Nashville
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
RecruitingPhase 1/2
- Sarah Cannon Research Institute, Nashville
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
RecruitingPhase 1/2
- The Sarah Cannon Research Institute/Tennessee Oncology, Nashville
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RecruitingPhase 3
- SCRI Oncology Partners, Nashville
- Vanderbilt Eye Institute, Nashville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecruitingPhase 2/3
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
RecruitingPhase 1/2
- SCRI Oncology Partners, Nashville
Uveal Melanoma trials in other cities
- Philadelphia, PA7 studies
- Los Angeles, CA6 studies
- Boston, MA5 studies
- Scottsdale, AZ5 studies
- Houston, TX5 studies
- New York City, NY5 studies
- Denver, CO5 studies
- Columbus, OH5 studies
- Aurora, CO4 studies
- Mountain View, CA4 studies
- Miami, FL4 studies
- Pittsburgh, PA4 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.